OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
33
Results
Show all
Save search
Copy query
Show results for
Unknown
(33)
Publication Date
Release Date
2023
(9)
2025
(5)
2024
(4)
2022
(4)
2021
(4)
2020
(4)
2016
(1)
2015
(1)
2010
(1)
Previous
page
1 / 4
You're on page
1
page
2
page
3
page
4
Next
page
Sort
by:
Relevance
Page size
10
Fluorescence-guided minimally-invasive resection of abdominal paragangliomas using indocyanine green.
Not available
S-EPMC10874414
|
biostudies-literature
Cite
Low penetrance of a SDHB mutation in a large Dutch paraganglioma family.
Not available
S-EPMC2891715
|
biostudies-literature
Cite
Local and systemic immune profiles of human pancreatic ductal adenocarcinoma revealed by single-cell mass cytometry.
Not available
S-EPMC9260840
|
biostudies-literature
Cite
Preclinical evaluation of a novel CEA-targeting near-infrared fluorescent tracer delineating colorectal and pancreatic tumors.
Not available
S-EPMC5080533
|
biostudies-literature
Cite
Completion pancreatectomy or a pancreas-preserving procedure during relaparotomy for pancreatic fistula after pancreatoduodenectomy: a multicentre cohort study and meta-analysis.
Not available
S-EPMC10364904
|
biostudies-literature
Cite
Video Grading of Pancreatic Anastomoses During Robotic Pancreatoduodenectomy to Assess Both Learning Curve and the Risk of Pancreatic Fistula: A Post Hoc Analysis of the LAELAPS-3 Training Program.
Not available
S-EPMC10549894
|
biostudies-literature
Cite
Prolonged antibiotic prophylaxis after pancreatoduodenectomy: systematic review and meta-analysis.
Not available
S-EPMC10564402
|
biostudies-literature
Cite
Complications After Major Surgery for Duodenopancreatic Neuroendocrine Tumors in Patients with MEN1: Results from a Nationwide Cohort.
Not available
S-EPMC8253708
|
biostudies-literature
Cite
Surgical Outcome After Pancreatoduodenectomy for Duodenal Adenocarcinoma Compared with Other Periampullary Cancers: A Nationwide Audit Study.
Not available
S-EPMC10027630
|
biostudies-literature
Cite
Total neoadjuvant FOLFIRINOX versus neoadjuvant gemcitabine-based chemoradiotherapy and adjuvant gemcitabine for resectable and borderline resectable pancreatic cancer (PREOPANC-2 trial): study protocol for a nationwide multicenter randomized controlled trial.
Not available
S-EPMC7989075
|
biostudies-literature
Cite
Previous
page
1 / 4
You're on page
1
page
2
page
3
page
4
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets